IGF1R and Alzheimer disease: As the disease progression is difficult to reverse, including Aβ accumulation formed in the late AD phase, the ineffectiveness of potent inducers of IGF-1 on AD patients might be due to the negative effects of IGF-1R on Aβ clearance.